Maharashtra, India

Prashant Dilip Wadekar


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prashant Dilip Wadekar: Innovator in Pharmaceutical Modulation

Introduction

Prashant Dilip Wadekar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate specific biological pathways. His work is essential in addressing various medical conditions.

Latest Patents

Wadekar holds a patent for "Bicyclic heteroaryl indole analogues useful as ROR gamma modulators." This patent describes compounds that are effective as modulators of retinoid-related orphan receptor gamma t (RORγt). These compounds are designed to prevent, inhibit, or suppress the action of RORγt, making them valuable in treating diseases such as pain, inflammation, chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases, and cancer. He has 1 patent to his name.

Career Highlights

Wadekar is currently associated with Glenmark Pharmaceuticals S.A., where he applies his expertise in pharmaceutical research and development. His role involves innovating new therapeutic solutions that can significantly impact patient care.

Collaborations

He collaborates with talented professionals in his field, including Sanjib Das and Sachin Sundarlal Chaudhari. These collaborations enhance the research and development efforts at Glenmark Pharmaceuticals.

Conclusion

Prashant Dilip Wadekar is a dedicated inventor whose work in pharmaceutical modulation is paving the way for new treatments for various diseases. His contributions are vital to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…